DSM and TU Delft launch a lab to apply artificial intelligence to biomanufacturing
Type of post: NEWS IN BRIEF.
Royal DSM and TU Delft have announced the establishment of the Artificial Intelligence Lab for Biosciences (the AI4B.io Lab). This laboratory will be the first of its kind in Europe to apply artificial intelligence (AI) to full-scale biomanufacturing, from microbial strain development to process optimization and scheduling.
Press release: “DSM and TU Delft launch AI4B.io Lab”, 11/01/2021.
Figure 1. DSM and TU Delft launch a lab to apply artificial intelligence to full-scale biomanufacturing
The AI4B.io Lab will be part of the Dutch National Innovation Center for AI (ICAI), which works to keep the Netherlands at the forefront of knowledge and talent development in AI. It will be led by Professor Marcel Reinders, Director TU Delft Bioengineering Institute. Although AI is already widely applied in engineering research, the AI4B.io Lab will be the first of its kind to explore AI’s potential in biosciences and biomanufacturing
With more than 150 years of experience, DSM has already developed an extensive portfolio of sustainable, biobased solutions. Now, developments in the understanding of biology, as well as major advances in digital transformation, are opening up exciting possibilities for new biobased products, applications and manufacturing processes. Integrating biosciences and digital technologies can help to reduce the time spent on innovation cycles, from prototyping to scaling and commercialization. So, DSM will invest 2.5 M€ into the laboratory over the first five years.